WASHINGTON (Reuters) - House of Representatives and Senate committees have agreed on legislation that would give the Food and Drug Administration greater authority to regulate companies that compound sterile drugs and ship them across state lines.




Source: U.S. congressional panels agree on bill to regulate drug compounding


David Cottle

UBB Owner & Administrator